0001209191-22-060587.txt : 20221209
0001209191-22-060587.hdr.sgml : 20221209
20221209193831
ACCESSION NUMBER: 0001209191-22-060587
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221206
FILED AS OF DATE: 20221209
DATE AS OF CHANGE: 20221209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Walker Marlan D
CENTRAL INDEX KEY: 0001820187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00100
FILM NUMBER: 221455941
MAIL ADDRESS:
STREET 1: 951 YAMATO ROAD
STREET 2: SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TherapeuticsMD, Inc.
CENTRAL INDEX KEY: 0000025743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870233535
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 YAMATO ROAD, SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
BUSINESS PHONE: 561-961-1900
MAIL ADDRESS:
STREET 1: 951 YAMATO ROAD, SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
FORMER COMPANY:
FORMER CONFORMED NAME: AMHN, Inc.
DATE OF NAME CHANGE: 20090930
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF ENTERPRISES INC
DATE OF NAME CHANGE: 19970915
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF OIL CO
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-06
0
0000025743
TherapeuticsMD, Inc.
TXMD
0001820187
Walker Marlan D
951 YAMATO ROAD
SUITE 220
BOCA RATON
FL
33431
0
1
0
0
General Counsel
Common Stock
2022-12-06
4
M
0
1010
0.00
A
6189
D
Common Stock
2022-12-06
4
M
0
1156
0.00
A
7345
D
Common Stock
2022-12-06
4
M
0
388
0.00
A
7733
D
Common Stock
2022-12-06
4
S
0
1048
4.9475
D
6685
D
Restricted Stock Unit
0.00
2022-12-06
4
M
0
1010
0.00
D
Common Stock
1010
1010
D
Restricted Stock Unit
0.00
2022-12-06
4
M
0
1156
0.00
D
Common Stock
1156
2311
D
Restricted Stock Unit
0.00
2022-12-06
4
M
0
388
0.00
D
Common Stock
388
770
D
Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).
The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $4.66 through $5.41, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
The RSUs vest in three equal installments annually, becoming fully vested on March 30, 2023.
The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.
Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024.
/s/ Marlan D. Walker
2022-12-09